ST6GAL1 and prostate neoplasm: Next, we analysed a second 125 case TMA29 to compare ST6GAL1 levels in localised prostate cancer tumours and prostate tumours presenting with metastasis to bone or lymph node (all biopsy samples were taken from the primary site) (Supplementary Table S1).